Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 12130
Country/Region: Malawi
Year: 2014
Main Partner: Baylor College of Medicine
Main Partner Program: Children's Foundation
Organizational Type: University
Funding Agency: USAID
Total Funding: $5,727,630 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

The goal of Baylor College of Medicine (Malawi)'s Tingathe program is to support PMTCT, Early Infant Diagnosis (EID), and HIV treatment services at health facilities, and facilitate prompt entry of infected children and adults into continuum of care for optimal treatment outcomes. Tingathe strengthens systems to improve the quality and utilization of PMTCT, EID, and adult and Pediatric HIV care services thereby contributing to the reduction of mortality and morbidity and, ultimately, the reduction of new HIV infections. These targeted interventions are priority areas of USG support under the Malawi partnership framework and GHI strategy.

Currently Tingathe operates in 20 sites in 6 districts.In COP14, Tingathe will expand to 126 sites in the South East Zone (SEZ) to strengthen pediatric HIV care and treatment services. Tingathe will continue to support 6 sites in Lilongwe and 6 sites in Salima but will drop off sites in Dowa, Kasungu, Mchinji and Ntcheu (priority sites in these 4 districts will be supported through other USG mechanisms). In these 12 sites, the Tingathe program will support adult and pediatric HIV clinical care and treatment services including PMTCT. Tingathe will conduct operations research to identify service delivery barriers and to develop strategies to overcome them. Building capacity of MoH staff is both a short and long term strategy for Baylor to ensure quality health services as well as continuity and sustainability of interventions even long after the Tingathe project closes out.

Through its robust monitoring and evaluation system, Baylor will improve adherence supervision and defaulter tracking activities. Baylor will implement high intensity standardized package of interventions (including HRH support) in all relevant technical areas.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $607,630
Care: TB/HIV (HVTB) $300,000
Care: Pediatric Care and Support (PDCS) $1,435,150
Strategic Information (HVSI) $100,000
Health Systems Strengthening (OHSS) $200,000
Testing: HIV Testing and Counseling (HVCT) $200,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $400,000
Treatment: Adult Treatment (HTXS) $584,850
Treatment: Pediatric Treatment (PDTX) $1,900,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 45,035
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 45,035
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 19,913
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 10,628
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 120,611
HTS_TST Sum of Aggregated Age/Sex <15 2015 90,070
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 30,541
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 120,611
PMTCT_ARV Life-long ART (including Option B+) 2015 753
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 849
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 753
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 376
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 377
PMTCT_ARV Sum of New and Current disaggregates 2015 753
PMTCT_ARV Sum of Regimen Type disaggregates 2015 753
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 19,087
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 9,544
PMTCT_STAT Number of new ANC and L&D clients 2015 13,468
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 12,429
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 25,426
TX_CURR Age/Sex: 15+ Male 2015 2,700
TX_CURR Aggregated Age/Sex: <15 Female 2015 9,693
TX_CURR Aggregated Age/Sex: <15 Male 2015 9,693
TX_CURR Aggregated Age/Sex: 15+ Female 2015 5,015
TX_CURR Aggregated Age/Sex: 15+ Male 2015 2,700
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 27,101
TX_CURR Sum of Aggregated Age/Sex <15 2015 19,386
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 7,715
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 27,101
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 2,960
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 2,960
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 1,344
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 749
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 8,013
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 8,013
Cross Cutting Budget Categories and Known Amounts Total: $3,756,078
Human Resources for Health $3,436,578
Gender: Gender Equality $319,500
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information